SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Entrada Therapeutics President & COO Nathan J

Entrada Therapeutics, Inc. · CLUSTER filed Mar 3, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Mar 3, 2026 at 19:00 ET

Entrada Therapeutics President & COO Nathan J. Dowden sold a total of 15,010 shares in the past week for approximately $195,771 in open-market transactions. The sales represent a modest insider divestment by a single C-suite executive.

  • President & COO Nathan J. Dowden sold 15,010 shares over two days (11,894 shares on 2026-03-10 at $13.0476; 3,116 shares on 2026-03-09 at $13.024).
  • Total proceeds from the sales were $195,770.93.
  • All transactions were open-market sales (Form 4 codes 'S').
  • No other insiders participated in this cluster.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access